Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: A study protocol for a pilot randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Carroll, Sandra L ^a,b   McGillion, Michael ^a,c   Stacey, Dawn ^d,e,f   Healey, Jeff S ^a,b,g   Browne, Gina ^a   Arthur, Heather M ^a,g   Thabane, Lehana ^a,b,h  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Heart and Stroke Foundation Michael G DeGroote Endowed Chair in Cardiovascular Nursing   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e University Research Chair in Knowledge Translation to Patients   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^g HAMILTON HEALTH SCIENCES   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

Decision aid; Decision making; Feasibility trial; Implantable defibrillator; Shared decision making

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; DECISION SUPPORT SYSTEM; DELPHI STUDY; DEPRESSION; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL RECORD; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY PREVENTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUDDEN CARDIAC DEATH;

ARRHYTHMIAS, CARDIAC; CLINICAL PROTOCOLS; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; DELPHI TECHNIQUE; ELECTRIC COUNTERSHOCK; FEASIBILITY STUDIES; HUMANS; ONTARIO; PATIENT PARTICIPATION; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROFESSIONAL-FAMILY RELATIONS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS;

EID: 84886908067     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-346     Document Type: Article

References (77)

1. Tang AS, Ross H, Simpson CS, Mitchell LB, Dorian P, Goeree R, et al. Canadian cardiovascular society/Canadian heart rhythm society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol 2005, 21:11A-18A.
2. Byrne R, Constant O, Smyth Y, Callagy G, Nash P, Daly K, et al. Multiple source surveillance incidence and etiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur Heart J 2008, 29:1418-1423. 10.1093/eurheartj/ehn155, 18424446.
3. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European society of cardiology. Eur Heart J 2001, 22:1374-1450. 10.1053/euhj.2001.2824, 11482917.
4. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De SG, et al. Heart disease and stroke statistics - 2010 update: a report from the American heart association.[erratum appears in circulation. 30 March 2010;121(12):e260 note: Stafford, Randall [corrected to Roger, Veronique L]]. Circulation 2010, 121:e46-e215.
5. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics versus implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study. Eur Heart J 2000, 21:2071-2078. 10.1053/euhj.2000.2476, 11102258.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med 2002, 346:877-883. 10.1056/NEJMoa013474, 11907286.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237. 10.1056/NEJMoa043399, 15659722.
8. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New Engl J Med 2004, 350:2151-2158. 10.1056/NEJMoa033088, 15152060.
9. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150. 10.1056/NEJMoa032423, 15152059.
10. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. New Engl J Med 1996, 335:1933-1940. 10.1056/NEJM199612263352601, 8960472.
11. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. New Engl J Med 2010, 363:2385-2395. 10.1056/NEJMoa1009540, 21073365.
12. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl J Med 2009, 361:1329-1338. 10.1056/NEJMoa0906431, 19723701.
13. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail 2006, 8:433-440. 10.1016/j.ejheart.2005.11.014, 16507349.
14. Wells G, Parkash R, Healey JS, Talajic M, Arnold JM, Sullivan S, et al. Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. CMAJ 2011, 183:421-429. 10.1503/cmaj.101685, 3050946, 21282316.
15. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol 2008, 51:e1-e62. 10.1016/j.jacc.2008.02.032, 18498951.
16. Fishman GI, Chugh SS, DiMarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a national heart, lung, and blood institute and heart rhythm society workshop. Circ 2010, 122:2335-2348.
17. Simpson CS, Hoffmaster B, Dorian P. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing. Can J Card 2005, 21:595-599.
18. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, et al. Pacemaker and ICD generator malfunctions. JAMA 2006, 295:1901-1906. 10.1001/jama.295.16.1901, 16639048.
19. Gould PA, Krahn AD, for the Canadian Heart Rhythm Society Working Group on Device Advisories Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006, 295:1907-1911. 10.1001/jama.295.16.1907, 16639049, for the Canadian Heart Rhythm Society Working Group on Device Advisories.
20. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009, 11:297-302. 10.1093/europace/eun322, 19054788.
21. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement/clinical perspective. Circ: Arrhythmia and Electrophysiology 2011, 4:136-142.
22. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Evaluation of early complications related to de novo cardioverter defibrillator implantation: insights from the Ontario ICD database. J Am Coll Cardiol 2010, 55:774-782. 10.1016/j.jacc.2009.11.029, 20170816.
23. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. [Update of Cochrane database syst Rev. 2009;(3):CD001431; PMID: 19588325]. Cochrane Database of Syst Rev 2011, 10:CD001431.
24. O'Connor AM. IPDAS Collaboration Background Document 2005, http://www.ipdas.ohri.ca/IPDAS_Background.pdf.
25. McAlister FA, Man-Son-Hing M, Straus SE, Ghali WA, Anderson D, Majumdar SR, et al. Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial. CMAJ 2005, 173:496-501. 10.1503/cmaj.050091, 1188186, 16129870.
26. Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation. JAMA 1999, 282:737-743. 10.1001/jama.282.8.737, 10463708.
27. Morgan M, Deber R, Llewellyn-Thomas H, Gladstone P, Cusimano R, O'Rourke K, et al. Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med 2000, 15:685-693. 10.1046/j.1525-1497.2000.91139.x, 1495608, 11089711.
28. Bernstein SJ, Skarupski KA, Grayson CE, Starling MR, Bates ER, Eagle KA. A randomized controlled trial of information-giving to patients referred for coronary angiography: effects on outcomes of care. Health Expect 1998, 1:50-61. 10.1046/j.1369-6513.1998.00007.x, 11281861.
29. Schwalm JD, Stacey D, Pericak D, Natarajan MK. Radial artery versus femoral artery access options in coronary angiogram procedures: randomized controlled trial of a patient-decision aid. Circ Cardiovasc Qual Outcomes 2012, 5:260-266. 10.1161/CIRCOUTCOMES.111.962837, 22496115.
30. Carroll SL, Strachan PH, de Laat S, Schwartz L, Arthur HM. Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expect 2013, 16:69-79. 10.1111/j.1369-7625.2011.00703.x, 3380066, 21645190.
31. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci & Med 1997, 44:681-692. 10.1016/S0277-9536(96)00221-3, 9032835.
32. Edwards A, Elwyn G. Shared Decision-making. Achieving Evidence-based Patient Choice 2009, Oxford: Oxford University Press.
33. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009, 32:1259-1271. 10.1111/j.1540-8159.2009.02495.x, 2757745, 19796343.
34. Dunbar SB, Jenkins LS, Hawthorne M, Kimble LP, Dudley WN, Slemmons M, et al. Factors associated with outcomes three months after implantable cardioverter defibrillator insertion. Heart Lung 1999, 28:303-315. 10.1053/hl.1999.v28.a101052, 10486447.
35. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004, 66:714-719. 10.1097/01.psy.0000132874.52202.21, 15385696.
36. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005, 149:664-669. 10.1016/j.ahj.2004.06.031, 15990750.
37. Sears SF, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clinl Cardio 1999, 22:481-489.
38. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life three months post-implantation. Europace 2007, 9:675-680. 10.1093/europace/eum041, 17434891.
39. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosom: J Consult Liaison Psychiatry 2005, 46:451-457.
40. Pedersen SS, Van Den Broek KC, Van Den Berg M, Theuns DA. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye?. Pace-Pacing Clin Electrophysiol 2010, 33:1430-1436.
41. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002, 87:488-493. 10.1136/heart.87.5.488, 1767118, 11997430.
42. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003, 5:381-389. 10.1016/S1099-5129(03)00078-3, 14753636.
43. Carroll SL, Markle-Reid M, Ciliska D, Connolly SJ, Arthur HM. Age and mental health predict early device-specific quality of life (QOL) in patients receiving prophylactic implantable defibrillators. Can J Card 2012, 28:502-507.
44. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 1998, 33:267-279. 10.1016/S0738-3991(98)00026-3, 9731164.
45. O'Connor AM. Ottawa Decision Support Framework 2006, http://decisionaid.ohri.ca/odsf.html.
46. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making 1998, 18:295-303. 10.1177/0272989X9801800307, 9679994.
47. Mitchell SL, Tetroe J, O'Connor AM. A decision aid for long-term tube feeding in cognitively impaired older persons. J Am Geriatr Soc 2001, 49:313-316. 10.1046/j.1532-5415.2001.4930313.x, 11300244.
48. Dales RE, O'Connor A, Hebert P, Sullivan K, McKim D, Llewellyn-Thomas H. Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences. Chest 1999, 116:792-800. 10.1378/chest.116.3.792, 10492288.
49. Cranney A, O'Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS, et al. Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns 2002, 47:245-255. 10.1016/S0738-3991(01)00218-X, 12088603.
50. Fiset V, O'Connor AM, Evans W, Graham I, DeGrasse C, Logan J. Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer. Health Expect 2000, 3:125-136. 10.1046/j.1369-6513.2000.00067.x, 11281919.
51. Metcalf KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, et al. Development and testing of a decision aid for breast cancer prevention for women with BRCA1 or BRCA2 mutation. Clin Genet 2007, 72:208-217. 10.1111/j.1399-0004.2007.00859.x, 17718858.
52. O'Connor AM, Edwards A. The role of decision aids in promoting evidence-based patient choice. Evidence-based Patient Choice: Inevitable or Impossible? 2001, 220-242. New York, NY: Oxford University Press, Edwards A, Elwyn G.
53. Gagnon M. Knowledge dissemination and exchange of knowledge. Knowledge Translation in Health Care: Moving from Evidence to Practice 2009, 235-245. Oxford: Wiley-Blackwell Publishing Ltd, Straus SE, Tetroe J, Graham ID.
54. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischemic or non-ischemic heart disease: a systematic review and meta-analysis. Europace 2010, 12:1564-1570. 10.1093/europace/euq329, 2963481, 20974768.
55. Ho C, Li H, Noorani H, Cimon K, Campbell K, Tang A, Birnie D. Implantable Cardiac Defibrillators for Primary Prevention of Sudden Cardiac Death in High Risk Patients: A Meta-analysis of Clinical Efficacy, and a Review of Cost-effectiveness and Psychosocial Issues, Technology report number 81 2007, Ottawa: Canadian Agency for Drugs and Technologies in Health.
56. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005, 46:2348-2356. 10.1016/j.jacc.2005.08.031, 16360070.
57. Keeney S, Hasson F, McKenna HP. A critical review of the Delphi technique as a research methodology for nursing. Int Journ Nurs Stud 2001, 38:195-200.
58. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000, 32:1008-1015.
59. O'Connor AM, Jacobsen MJ. Workbook on Developing and Evaluating Patient Decision Aids 2003, http://www.ohri.ca/decisionaid.
60. O'Connor AM, Cranney A. User Manual - Acceptability 2002, 1-5. Ottawa Hospital Research Institute, http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Acceptability.pdf, 1-6-2011.
61. Medical Research Council Health Services and Public Health Research Board A Framework for Development and Evaluation of RCT's for Complex Interventions to Improve Health 2000, UK: Medical Research Council, Medical Research Council Health Services and Public Health Research Board.
62. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010, 10:1. 10.1186/1471-2288-10-1, 2824145, 20053272.
63. McHorney CA, War JE, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66. 10.1097/00005650-199401000-00004, 8277801.
64. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas 1977, 1:385-401.
65. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977, 106:203-214.
66. The Criteria Committee of the New York Heart Association Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels 1994, Boston, MA: Little Brown, 9, The Criteria Committee of the New York Heart Association.
67. Matlock DD, Nowels CT, Bekelman DB. Patient perspectives on decision making in heart failure. J Card Fail 2010, 16:823-826. 10.1016/j.cardfail.2010.06.003, 20932464.
68. O'Connor AM. User Manual-decisional Conflict Scale [Document on the internet] Ottawa: Ottawa Hospital Research Institute, © 1993 [updated 2010]: 16p. http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf.
69. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995, 15:25-30. 10.1177/0272989X9501500105, 7898294.
70. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009, Issue 3. Art. No:CD001431. DOI: 10.1002/14651858.CD001431.pub2.
71. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns 2010, 78:130-133. 10.1016/j.pec.2009.05.012, 19560303.
72. Graham ID, O'Connor AM. User Manual-preparation for Decision Making Scale 2010, 1-3. Ottawa Hospital Research Institute, http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_PrepDM.pdf, 1-6-2011.
73. Norman GR, Streiner DL. Biostatistics: The Bare Essentials 2008, Hamilton: BC Decker Inc, 3.
74. Ryan GW, Bernard HR. Techniques to identify themes. Field Methods 2003, 15:85-109.
75. Thorne S, Kirkham SR, O'Flynn-Magee K. The analytic challenge in interpretive description. Int J Qualitative Methods 2004, 3:1-11.
76. Thorne S, Kirkham SR, MacDonald-Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health 1997, 20:169-177. 10.1002/(SICI)1098-240X(199704)20:2<169::AID-NUR9>3.0.CO;2-I, 9100747.
77. Garrett DD, Tuokko H, Stajduhar KI, Lindsay J, Buehler S. Planning for end-of-life care: findings from the Canadian study of health and aging. Can J Aging 2008, 27:11-21. 10.3138/cja.27.1.11, 18492633.